The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia
Open accessAbstract
Little is known about the physiological roles of the M 5 muscarinic receptor, the last member of the muscarinic receptor family (M 1 –M 5 ) to be cloned. In the brain, the M 5 receptor subtype is preferentially expressed by dopaminergic neurons of the substantia nigra and the ventral tegmental area. Dopaminergic neurons located in the ventral tegmental area are known to play important roles in mediating both the rewarding effects of opiates and other drugs of abuse and the manifestations of opiate/drug withdrawal symptoms. We therefore speculated that acetylcholine-dependent activation of M 5 receptors might modulate the manifestations of opiate reward and withdrawal. This hypothesis was tested in a series of behavioral, biochemical, and neurochemical studies using M 5 receptor-deficient mice (M 5 −/− mice) as novel experimental tools. We found that the rewarding effects of morphine, as measured in the conditioned place preference paradigm, were substantially reduced in M 5 −/− mice. Furthermore, both the somatic and affective components of naloxone-induced morphine withdrawal symptoms were significantly attenuated in M 5 −/− mice. In contrast, the analgesic efficacy of morphine and the development of tolerance to the analgesic effects of morphine remained unaltered by the lack of M 5 receptors. The finding that M 5 receptor activity modulates both morphine reward and withdrawal processes suggests that M 5 receptors may represent a novel target for the treatment of opiate addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Forster, G. L., & Blaha, C. D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00250.x · Cited by 271
Research works printed but not linked: 31
- 10.1016/0896-6273(88)90190-0 · DOI · Paper page
- 10.1016/S0021-9258(18)83237-9 · DOI · Paper page
- 10.1615/CritRevNeurobiol.v10.i1.40 · DOI · Paper page
- Caulfield M. P. & Birdsall, N. J. M. (1998) Pharmacol. Rev.50,279-290.9647869
- 10.1016/S0024-3205(97)00054-4 · DOI
- 10.1038/sj.bjp.0703276 · DOI
- 10.1073/pnas.251542998 · DOI · Paper page
- Yasuda R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V. & Wolfe, B. B. (1993) Mol. Pharmacol.43,149-157.8429821
- 10.1016/0304-3940(90)90064-G · DOI · Paper page
- 10.1073/pnas.87.18.7050 · DOI · Paper page
- 10.1523/JNEUROSCI.22-01-j0001.2002 · DOI
- 10.1523/JNEUROSCI.15-09-05859.1995 · DOI · Paper page
- 10.1523/JNEUROSCI.16-02-00714.1996 · DOI · Paper page
- 10.1016/S0959-4388(96)80079-1 · DOI · Paper page
- Lacey M. G., Calabresi, P. & North, R. A. J. (1990) J. Pharmacol. Exp. Ther.253,395-400.2329522
- 10.1016/S0091-3057(96)00467-4 · DOI
- 10.1016/S0028-3908(99)00080-5 · doi:10.1016/s0028-3908(99)00080-5
- 10.1007/s002130050002 · DOI
- Fedorova I., Hashimoto, A., Fecik, R. A., Hedrick, M. P., Hanus, L. O., Boger, D. L., Rice, K. C. & Basile, A. S. (2001) J. Pharmacol. Exp. Ther.299,322-342.
- Pani A. K. Shippenberg T. S. Heidebreder C. & Espey M. G. (1997) in Current Protocols in Neuroscience eds. Crawley J. N. Gerfen C. R. Rogawski M. A. Sibley D. R. & Skolnick P. (Wiley New York).
- 10.1016/0165-0270(93)90097-B · DOI · Paper page
- 10.1002/1098-2396(200008)37:2<118::AID-SYN6>3.0.CO;2-2 · doi:10.1002/1098-2396(200008)37:2<118::aid-syn6>3.0.co;2-2
- 10.1046/j.1471-4159.1995.65031124.x · DOI
- 10.1073/pnas.96.18.10483 · DOI · Paper page
- Nye H. E. & Nestler, E. J. (1996) Mol. Pharmacol.49,636-645.8609891
- 10.1016/S0301-0082(98)00060-4 · DOI · Paper page
- 10.1038/41567 · DOI · Paper page
- 10.1038/35012069 · DOI · Paper page
- 10.1615/CritRevNeurobiol.v12.i4.10 · DOI
- 10.1523/JNEUROSCI.20-23-08861.2000 · DOI
- O'Brien C. P. (2001) in The Pharmacological Basis of Therapeutics eds. Hardman J. G. & Limbird L. E. (McGraw-Hill New York) pp. 621–642.
Cited by
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Self-citationMuscarinic acetylcholine receptors as CNS drug targets
Langmead, C. J., Watson, J., & Reavill, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 419
Metadata
- Authors
- Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-08
- Volume
- 99
- Issue
- 17
- Pages
- 11452-11457
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2028310558
- Cited by
- 195
- References
- 5
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. https://app.cochat.ai/papers/10.1073/pnas.162371899
- The paper
- Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J. (2002). Deletion of the M 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.162371899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.